Stage IIIC Fallopian Tube Cancer AJCC v7

specific

Stage III includes: (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T3c, N0, M0); (Any T, N1, M0). T3: Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis. T3a: Microscopic peritoneal metastasis outside the pelvis. T3b: Macroscopic peritoneal metastasis outside the pelvis 2 cm or less in greatest dimension. T3c: Peritoneal metastasis outside the pelvis and more than 2 cm in diameter. N0: No regional lymph node metastasis. N1: Regional lymph n

72

Centers

91

Active Trials

Cancer Funding

Top Centers for Stage IIIC Fallopian Tube Cancer AJCC v7(72)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.9
2
NCI Comprehensive
Active Research Program
64.4
3
NCI Comprehensive
Active Research Program
64.4
4
NCI Comprehensive
Active Research Program
64.4
5
NCI Comprehensive
Active Research Program
64.4
6
NCI Comprehensive
Active Research Program
64.4
7
NCI Comprehensive
Active Research Program
64.4
8
NCI Comprehensive
Active Research Program
64.4
9
NCI Comprehensive
Active Research Program
64.4
10
NCI Comprehensive
Active Research Program
64.4
11
NCI Comprehensive
Active Research Program
64.4
12
NCI Comprehensive
Active Research Program
64.4
13
Active Research Program
64.4
14
Active Research Program
64.4
15
NCI Clinical
Active Research Program
64.4
16
Active Research Program
64.4
17
NCI Clinical
Active Research Program
64.4
18
NCI Comprehensive
Active Research Program
64.4
19
Active Research Program
64.4
20
Active Research Program
64.4
2164.4
22
Active Research Program
64.4
23
Active Research Program
64.4
24
Active Research Program
64.4
25
Active Research Program
64.4
26
Active Research Program
64.4
27
Active Research Program
64.4
28
NCI Comprehensive
Active Research Program
45.1
29
NCI Comprehensive
Active Research Program
45.1
30
NCI Comprehensive
Active Research Program
45.1
31
NCI Comprehensive
Active Research Program
45.1
32
NCI Comprehensive
Active Research Program
45.1
33
NCI Comprehensive
Active Research Program
45.1
34
NCI Comprehensive
Active Research Program
45.1
35
NCI Comprehensive
Active Research Program
45.1
36
NCI Comprehensive
Active Research Program
45.1
37
NCI Comprehensive
Active Research Program
45.1
38
NCI Comprehensive
Active Research Program
45.1
39
NCI Comprehensive
Active Research Program
45.1
40
NCI Comprehensive
Active Research Program
45.1
41
NCI Comprehensive
Active Research Program
45.1
42
NCI Comprehensive
Active Research Program
45.1
43
NCI Comprehensive
Active Research Program
45.1
44
NCI Clinical
Active Research Program
45.1
45
NCI Comprehensive
Active Research Program
45.1
46
NCI Comprehensive
Active Research Program
45.1
47
NCI Comprehensive
Active Research Program
45.1
48
NCI Clinical
Active Research Program
45.1
49
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
45.1
50
NCI Comprehensive
Active Research Program
45.1
51
Active Research Program
45.1
52
NCI Comprehensive
Active Research Program
45.1
53
NCI Comprehensive
Active Research Program
45.1
54
NCI Comprehensive
Active Research Program
45.1
55
NCI Comprehensive
Active Research Program
45.1
56
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
45.1
57
NCI Comprehensive
Active Research Program
45.1
58
Active Research Program
45.1
59
Active Research Program
45.1
60
Active Research Program
45.1
61
Active Research Program
45.1
62
Active Research Program
45.1
63
Active Research Program
45.1
64
NCI Comprehensive
31.0
65
NCI Comprehensive
31.0
66
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
31.0
67
NCI Comprehensive
31.0
68
NCI Comprehensive
31.0
69
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
31.0
70
NCI Basic_laboratory
31.0
7131.0
7231.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →